ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,598Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 939

$627K Total Retail Price of All Prescriptions

Rank: 158 out of 939

638 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 638 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 638 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 14,454 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 763 664 1 4
SIMVASTATIN 730 675 2 2
OMEPRAZOLE 644 555 3 5
LISINOPRIL 607 515 4 3
AMLODIPINE BESYLATE 592 517 5 6
HYDROCODONE-ACETAMINOPHEN 568 344 S3 6 1
PRAVASTATIN SODIUM 534 463 7 13
POTASSIUM CHLORIDE 459 405 8 9
TRIAMTERENE-HCTZ 416 366 9 33
METOPROLOL TARTRATE 399 338 10 10
FUROSEMIDE 382 315 11 7
METOPROLOL SUCCINATE 365 321 12 21
METFORMIN HCL 357 276 13 8
ZOLPIDEM TARTRATE 326 244 14 20
WARFARIN SODIUM 292 249 15 17
HYDROCHLOROTHIAZIDE 284 245 16 12
MELOXICAM 236 206 17 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 224 166 18 23
TRIAMTERENE-HYDROCHLOROTHIAZID 208 199 19 115
TRAMADOL HCL 207 175 20 16
FLUTICASONE PROPIONATE 193 162 21 43
DONEPEZIL HCL 187 173 22 30
ATORVASTATIN CALCIUM 165 157 23 22
GABAPENTIN 164 116 24 11
LOVASTATIN 158 102 25 46
SERTRALINE HCL 151 133 26 24
CITALOPRAM HBR 150 119 27 15
AMLODIPINE BESYLATE-BENAZEPRIL 141 117 28 58
NEXIUM 140 81 29 18
LOSARTAN-HYDROCHLOROTHIAZIDE 136 113 30 55
FAMOTIDINE 135 96 31 62
DIGOXIN 134 128 32 45
AMITRIPTYLINE HCL 132 85 R 33 38
ALLOPURINOL 130 116 34 31
SUCRALFATE 120 84 35 96
GLYBURIDE 118 88 R 36 89
RISPERIDONE 118 111 36 82
KLOR-CON M20 115 83 38 90
TAMSULOSIN HCL 108 108 39 27
ALENDRONATE SODIUM 108 96 39 40
CLOPIDOGREL 107 84 41 28
PLAVIX 105 85 42 48
CYCLOBENZAPRINE HCL 101 34 R 43 36
QUETIAPINE FUMARATE 98 89 44 69
ATENOLOL 95 89 45 19
LOSARTAN POTASSIUM 91 89 46 29
PREDNISONE 89 75 47 42
NAPROXEN 89 57 47 72
NIASPAN 87 66 49 183
CIPROFLOXACIN HCL 83 67 50 54
ISOSORBIDE MONONITRATE ER 82 70 51 53
SPIRONOLACTONE 81 53 52 71
GLYBURIDE-METFORMIN HCL 80 69 R 53 98
DIOVAN HCT 75 58 54 74
VENLAFAXINE HCL 74 69 55 159
AZITHROMYCIN 72 60 56 32
POLYETHYLENE GLYCOL 3350 72 72 56 57
DIOVAN 72 71 56 50
ENALAPRIL MALEATE 72 57 56 65
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 53 56 64
DOXYCYCLINE HYCLATE 72 54 56 84
PROPRANOLOL HCL 71 36 62 117
NIFEDICAL XL 70 56 63 259
VERAPAMIL ER 70 66 63 85
NAMENDA 68 68 65 49
CLONIDINE HCL 67 51 66 39
PANTOPRAZOLE SODIUM 66 36 67 66
CARVEDILOL 64 51 68 25
OXYBUTYNIN CHLORIDE 63 61 69 125
TRAZODONE HCL 56 33 70 26
DILTIAZEM 24HR CD 56 56 70 126
ADVAIR DISKUS 54 36 72 60
CRESTOR 52 52 73 34
FLUOXETINE HCL 51 20 74 47
LANTUS 51 23 74 59
PREMARIN 50 38 R 76 111
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.